Amalgamated Bank’s Enanta Pharmaceuticals ENTA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5K | Hold |
667
| – | – | ﹤0.01% | 2729 |
|
|
2025
Q1 | $4K | Hold |
667
| – | – | ﹤0.01% | 2713 |
|
|
2024
Q4 | $4K | Hold |
667
| – | – | ﹤0.01% | 2782 |
|
|
2024
Q3 | $7K | Hold |
667
| – | – | ﹤0.01% | 2609 |
|
|
2024
Q2 | $9K | Hold |
667
| – | – | ﹤0.01% | 2502 |
|
|
2024
Q1 | $12K | Sell |
667
-1,208
| -64% | -$21.7K | ﹤0.01% | 2352 |
|
|
2023
Q4 | $18K | Sell |
1,875
-198
| -10% | -$1.9K | ﹤0.01% | 2697 |
|
|
2023
Q3 | $23K | Sell |
2,073
-5,565
| -73% | -$61.7K | ﹤0.01% | 2577 |
|
|
2023
Q2 | $163K | Sell |
7,638
-646
| -8% | -$13.8K | ﹤0.01% | 1895 |
|
|
2023
Q1 | $335K | Sell |
8,284
-597
| -7% | -$24.1K | ﹤0.01% | 1597 |
|
|
2022
Q4 | $413K | Hold |
8,881
| – | – | ﹤0.01% | 1552 |
|
|
2022
Q3 | $461K | Buy |
8,881
+399
| +5% | +$20.7K | ﹤0.01% | 1472 |
|
|
2022
Q2 | $401K | Buy |
8,482
+86
| +1% | +$4.07K | ﹤0.01% | 1563 |
|
|
2022
Q1 | $598K | Sell |
8,396
-352
| -4% | -$25.1K | ﹤0.01% | 1470 |
|
|
2021
Q4 | $654K | Sell |
8,748
-256
| -3% | -$19.1K | ﹤0.01% | 1442 |
|
|
2021
Q3 | $512K | Sell |
9,004
-149
| -2% | -$8.47K | ﹤0.01% | 1569 |
|
|
2021
Q2 | $403K | Buy |
+9,153
| New | +$403K | ﹤0.01% | 1747 |
|
|
2020
Q1 | – | Sell |
-3,348
| Closed | -$207K | – | 1711 |
|
|
2019
Q4 | $207K | Buy |
+3,348
| New | +$207K | ﹤0.01% | 1623 |
|
|
2019
Q3 | – | Sell |
-3,228
| Closed | -$272K | – | 1784 |
|
|
2019
Q2 | $272K | Buy |
3,228
+492
| +18% | +$41.5K | 0.01% | 1411 |
|
|
2019
Q1 | $261K | Buy |
+2,736
| New | +$261K | 0.01% | 1348 |
|
|
2018
Q3 | – | Sell |
-2,714
| Closed | -$315K | – | 1501 |
|
|
2018
Q2 | $315K | Buy |
+2,714
| New | +$315K | 0.01% | 1292 |
|